Screener
Merit Medical Systems MMSI Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Fair value adjustments related to contingent consideration liabilities | (179) | 1,023 |
| Amortization of deferred credits | (26) | (26) |
| Amortization of long-term debt issuance costs | 1,414 | 1,414 |
| Stock-based compensation expense | 8,961 | 9,078 |
| Changes in operating assets and liabilities, net of acquisitions and divestitures: | ||
| Trade receivables | (3,577) | (7,560) |
| Other receivables | 2,067 | (284) |
| Inventories | (22,655) | (10,599) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's stock-based comp?
- Merit Medical Systems (MMSI) reported stock-based comp of $8.96M in Q1 2026.
- How has Merit Medical Systems's stock-based comp changed year-over-year?
- Merit Medical Systems's stock-based comp decreased by 1.3% year-over-year, from $9.08M to $8.96M.
- What is the long-term trend for Merit Medical Systems's stock-based comp?
- Over 4 years (2021 to 2025), Merit Medical Systems's stock-based comp has grown at a 28.2% compound annual growth rate (CAGR), from $16.09M to $43.46M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Merit Medical Systems's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude